Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia

British Journal of Haematology

Volumn 144, Issue 1, 2009, Pages 69-77

  Salim, Juan P ^a   Goette, Nora P ^a   Lev, Paola R ^a   Chazarreta, Carlos D ^a   Heller, Paula G ^a   Alvarez, Clarisa ^a   Molinas, Felisa C ^a   Marta, Rosana F ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

Chemokines; CXCR4; Essential thrombocythemia; Platelets; Stromal derived factor 1

Indexed keywords

CD34 ANTIBODY; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 8; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL HYPERPLASIA; CELL LINEAGE; CELL SURFACE; CHILD; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; ONCOGENE; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE MEMBRANE; THROMBOCYTHEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CASE-CONTROL STUDIES; CHEMOKINE CXCL1; CHEMOKINE CXCL12; CHILD; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MALE; MEGAKARYOCYTES; MIDDLE AGED; PLATELET AGGREGATION; RECEPTORS, CXCR4; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOCYTHEMIA, ESSENTIAL;

EID: 57449096342     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07428.x     Document Type: Article

References (42)

1. Abi-Younes, S., Sauty, A., Mach, F., Sukhova, G.K., Libby, P. Luster, A.D. (2000) The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circulation Research, 86, 131 138.
2. Avecilla, S.T., Hattori, K., Heissig, B., Tejada, R., Liao, F., Shido, K., Jin, D.K., Dias, S., Zhang, F., Hartman, T.E., Hackett, N.R., Crystal, R.G., Witte, L., Hicklin, D.J., Bohlen, P., Eaton, D., Lyden, D., de Sauvage, F. Rafii, S. (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nature Medicine, 10, 64 71.
3. Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N. Green, A.R. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 1054 1061.
4. Bellucci, S., Legrand, C., Boval, B., Drouet, L. Caen, J. (1999) Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with anagrelide. British Journal of Haematology, 104, 886 892.
5. Berthebaud, M., Riviere, C., Jarrier, P., Foudi, A., Zhang, Y., Compagno, D., Galy, A., Vainchenker, W. Louache, F. (2005) RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. Blood, 106, 2962 2968.
6. Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. Springer, T.A. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 382, 829 833.
7. Bogani, C., Ponziani, V., Guglielmelli, P., Desterke, C., Rosti, V., Bosi, A., Le Bousse-Kerdilès, M.C., Barosi, G. Vannucchi, A.M. (2008) Hypermethylation of CXCR4 Promoter in CD34+ Cells from Patients with Primary Myelofibrosis. Stem Cells, 26, 1920 1930.
8. Born, G.V.R. (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 194, 927 929.
9. Busillo, J.M. Benovic, J.L. (2007) Regulation of CXCR4 signaling. Biochimica Biophysica Acta, 1768, 952 963.
10. Campbell, P.J. Green, A.R. (2006) The myeloproliferative disorders. The New England Journal of Medicine, 355, 2452 2466.
11. Cesar, J.M., de Miguel, D., Garcia Avello, A. Burgaleta, C. (2005) Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100. American Journal of Clinical Pathology, 123, 772 777.
12. Charo, I.F. Ransohoff, R.M. (2006) The many roles of chemokines and chemokine receptors in inflammation. The New England Journal of Medicine, 354, 610 621.
13. Chomczynski, P. Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol - chloroform extraction. Analytical Biochemistry, 162, 156 159.
14. Cooper, B., Schafer, A.I., Puchalsky, D. Handin, R.I. (1978) Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders. Blood, 52, 618 626.
15. Cortelazzo, S., Viero, P., Bassan, R. Barbui, T. (1981) Spectrum of platelet aggregation abnormalities in myeloproliferative diseases. La Ricerca in Clinica e in Laboratorio, 11, 35 42.
16. Emadi, S., Clay, D., Desterke, C., Guerton, B., Maquarre, E., Charpentier, A., Jasmin, C. Le Bousse-Kerdilès, M.C. (2004) IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation and ploidy in myeloid metaplasia with myelofibrosis. Blood, 105, 464 473.
17. Esche, C., Stellato, C. Beck, L.A. (2005) Chemokines: key players in innate and adaptive immunity. The Journal of Investigative Dermatology, 125, 615 628.
18. Gear, A.R., Suttitanamongkol, S., Viisoreanu, D., Polanowska-Grabowska, R.K., Raha, S. Camerini, D. (2001) Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood, 97, 937 945.
19. Gewirtz, A.M., Zhang, J., Ratajczak, J., Ratajczak, M., Park, K.S., Li, C., Yan, Z. Poncz, M. (1995) Chemokine regulation of human megakaryocytopoiesis. Blood, 86, 2559 2567.
20. Goerttler, P.S., Steimle, C., März, E., Johansson, P.L., Andreasson, B., Griesshammer, M., Gisslinger, H., Heimpel, H. Pahl, H.L. (2005) The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients. Blood, 106, 2862 2864.
21. Guerriero, R., Mattia, G., Testa, U., Chelucci, C., Macioce, G., Casella, I., Samoggia, P., Peschle, C. Hassan, H.J. (2001) Stromal cell-derived factor 1α increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood, 97, 2587 2595.
22. Guglielmelli, P., Zini, R., Bogani, C., Salati, S., Pancrazzi, A., Bianchi Mannelli, E.F., Ferrari, S., Le Bousse-Kerdilès, M.C., Bosi, A., Barosi, G., Migliaccio, A.R., Manfredini, R. Vannucchi, A.M. (2007) Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Willms′ tumor gene 1 (WT1). Stem Cells, 25, 165 173.
23. Hamada, T., Möhle, R., Hesselgesser, J., Hoxie, J., Nachman, R.L., Moore, M.A. Rafii, S. (1998) Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. The Journal of Experimental Medicine, 188, 539 548.
24. Harrison, C.N. (2005) Essential thrombocythemia: challenges and evidence-based management. British Journal of Haematology, 130, 153 165.
25. Heller, P.G., Lev, P.R., Salim, J.P., Kornblihtt, L.I., Goette, N.P., Chazarreta, C.D., Glembotsky, A.C., Vassallu, P.S., Marta, R.F. Molinas, F.C. (2006) JAK2 mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status. European Journal of Haematology, 77, 210 216.
26. Hermouet, S., Godard, A., Pineau, D., Corre, I., Raher, S., Lippert, E. Jacques, Y. (2002) Abnormal production of interleukin (IL)-11 and IL- 8 in polycythaemia vera. Cytokine, 20, 178 183.
27. Horikawa, Y., Matsumura, I., Hashimoto, K., Shiraga, M., Kosugi, S., Tadokoro, S., Kato, T., Miyazaki, H., Tomiyama, Y., Kurata, Y., Matsuzawa, Y. Kanakura, Y. (1997) Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood, 90, 4031 4038.
28. Kowalska, M., Ratajczak, J., Hoxie, J., Brass, L.F., Gewirtz, A., Poncz, M. Ratajczak, M.Z. (1999) Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets. British Journal of Haematology, 104, 220 229.
29. Kowalska, M.A., Ratajczak, M.Z., Majka, M., Jin, J., Kunapuli, S., Brass, L. Poncz, M. (2000) Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets. Blood, 96, 50 57.
30. Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M. Skoda, R.C. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. The New England Journal of Medicine, 352, 1779 1790.
31. Levine, R.L., Wadleigh, M., Cools, J., Ebert, B.L., Wernig, G., Huntly, B.J., Boggon, T.J., Wlodarska, I., Clark, J.J., Moore, S., Adelsperger, J., Koo, S., Lee, J.C., Gabriel, S., Mercher, T., D'Andrea, A., Fröhling, S., Döhner, K., Marynen, P., Vandenberghe, P., Mesa, R.A., Tefferi, A., Griffin, J.D., Eck, M.J., Sellers, W.R., Meyerson, M., Golub, T.R., Lee, S.J. Gilliland, D.G. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387 397.
32. Majka, M., Janowska-Wieczorek, A., Ratajczak, J., Kowalska, M.A., Vilaire, G., Pan, Z.K., Honczarenko, M., Marquez, L.A., Poncz, M. Ratajczak, M.Z. (2000) Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood, 96, 4142 4151.
33. Mazzucato, M., De Marco, L., De Angelis, V., De Roia, D., Bizzaro, N. Casonato, A. (1989) Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor function. British Journal of Haematology, 73, 369 374.
34. Minamiguchi, H., Kimura, T., Urata, Y., Miyazaki, H., Bamba, T., Abe, T. Sonoda, Y. (2001) Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathway. British Journal of Haematology, 115, 175 185.
35. Mori, T., Kim, J., Yamano, T., Takeuchi, H., Huang, S., Umetani, N., Koyanagi, K. Hoon, D.S. (2005) Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Research, 65, 1800 1807.
36. Murphy, S., Peterson, P., Iland, H. Laszlo, J. (1997) Experience of the Polycythemia vera study group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Seminars in Hematology, 34, 29 39.
37. Pardanani, A.D., Levine, R.L., Lasho, T., Pikman, Y., Mesa, R.A., Wadleigh, M., Steensma, D.P., Elliott, M.A., Wolanskyj, A.P., Hogan, W.J., McClure, R.F., Litzow, M.R., Gilliland, D.G. Tefferi, A. (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood, 108, 3472 3476.
38. Riviere, C., Subra, F., Cohen-Solal, K., Cordette-Lagarde, V., Letestu, R., Auclair, C., Vainchenker, W. Louache, F. (1999) Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesis. Blood, 93, 1511 1523.
39. Rollins, B.J. (1997) Chemokines. Blood, 90, 909 928.
40. Rosti, V., Massa, M., Vannucchi, A., Bergamaschi, G., Campanelli, R., Pecci, A., Viarengo, G., Meli, V., Marchetti, M., Guglielmelli, P., Bruno, E., Xu, M., Hoffman, R. Barosi, G. (2007) The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia. Blood Cells, Molecules & Diseases, 38, 280 286.
41. Sato, M., Matsubayashi, H., Fukushima, N. Goggins, M. (2005) The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer. Cancer Biology & Therapy, 4, 70 76.
42. Wang, J.F., Liu, Z.Y. Groopman, J.E. (1998) The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood, 92, 756 764.